Stay updated with breaking news from Ellen Lubman. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Company to present an update of its ongoingmonotherapy and combinationPhase 1/1b study of WTX-124 in advanced or metastatic solid tumors
04.01.2024 - WATERTOWN, Mass., Jan. 04, 2024 (GLOBE NEWSWIRE) - Werewolf Therapeutics, Inc. (the “Company” or “Werewolf”) (Nasdaq: HOWL), an innovative biopharmaceutical company pioneering the development of novel, conditionally activated INDUKINE therapeutics ...
Bergen, Norway, December 20, 2023 – Cytovation ASA, a clinical stage immune-oncology company focused on the development of its first-in-class targ...
DURHAM, N.C.--(BUSINESS WIRE)--#GeneCentric--GeneCentric Therapeutics, a company making precision medicine more precise through RNA-based diagnostics, today announced the appointment of Prasanth Reddy, MD, MPH, FACP, and Don Hardison as independent directors of its Board of Directors.Dr. Reddy is triple board-certif...
– Preliminary data from the WTX-124 monotherapy dose-escalation arm of the ongoing Phase 1/1b clinical trial provide compelling early evidence of...